Hormone and reproductive factors and risk of systemic lupus erythematosus: a Mendelian randomized study
- 6 April 2024
- journal article
- research article
- Published by Springer Nature in Immunologic Research
- Vol. 72 (4) , 665-674
Abstract
Systemic lupus erythematosus (SLE) is an autoimmune and inflammatory disease with a risk associated with hormonal and reproductive factors. However, the potential causal effects between these factors and SLE remain unclear. A two-sample Mendelian randomization study was conducted using the published summary data from the genome-wide association study database. Five independent genetic variants associated with hormonal and reproductive factors were selected as instrumental variables: age at menarche, age at natural menopause, estradiol, testosterone, and follistatin. To estimate the causal relationship between these exposure factors and disease outcome, we employed the inverse-variance weighted, weighted median, and MR-Egger methods. In addition, we carried out multiple sensitivity analyses to validate model assumptions. Inverse variance weighted showed that there was a causal association between circulating follistatin and SLE risk (OR = 1.38, 95% CI 1.03 to 1.86, P = 0.033). However, no evidence was found that correlation between AAM (OR = 1.04, 95% CI 0.77 to 1.40, P = 0.798), ANM (OR = 0.99, 95% CI 0.92 to 1.06, P = 0.721), E2 (OR = 1.40, 95% CI 0.14 to 13.56, P = 0.772), T (OR = 1.25, 95% CI 0.70 to 2.28, P = 0.459), and SLE risk. Our study revealed that elevated circulating follistatin associates with an increased risk of SLE. This finding suggests that the regulatory signals mediated by circulating follistatin may provide a potential mechanism relevant to the treatment of SLE.Keywords
Funding Information
- National Natural Science Foundation of China (No.81973778)
This publication has 50 references indexed in Scilit:
- Dyslipidemia is associated with inflammation and organ involvement in systemic lupus erythematosusClinical Rheumatology, 2023
- Insights into modifiable risk factors of cholelithiasis: A Mendelian randomization studyHepatology, 2021
- In-hospital mortality reduction in systemic lupus erythematosus over 2 decades varied by patient sex and ageClinical Rheumatology, 2021
- Meta‐analysis andMendelianrandomization: A reviewResearch Synthesis Methods, 2019
- Mendelian RandomizationJAMA, 2017
- Interpreting findings from Mendelian randomization using the MR-Egger methodEuropean Journal of Epidemiology, 2017
- Effect of Corticosteroids and Cyclophosphamide on Sex Hormone Profiles in Male Patients With Systemic Lupus Erythematosus or Systemic SclerosisArthritis & Rheumatology, 2017
- Reproductive and menopausal factors and risk of systemic lupus erythematosus in womenArthritis & Rheumatism, 2007
- Hormonal and reproductive risk factors for development of systemic lupus erythematosus: Results of a population‐based, case–control studyArthritis & Rheumatism, 2002
- Systemic lupus erythematosus and reproductive function: A case-control studyAmerican Journal of Obstetrics and Gynecology, 1985